Search Results - "WATT, Rosemary"

Refine Results
  1. 1

    Predicting future risk of asthma exacerbations using individual conditional probabilities by Thamrin, Cindy, PhD, Zindel, Joel, Nydegger, Regula, MD, Reddel, Helen K., MBBS, PhD, Chanez, Pascal, MD, PhD, Wenzel, Sally E., MD, FitzPatrick, Susan, BS, Watt, Rosemary A., PhD, Suki, Béla, PhD, Frey, Urs, MD, PhD

    Published in Journal of allergy and clinical immunology (01-06-2011)
    “…Background Determination of future risk of exacerbations is a key issue in the management of asthma. We previously developed a method to calculate conditional…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Validation and important differences for the Sarcoidosis Assessment Tool. A new patient-reported outcome measure by Judson, Marc A, Mack, Michael, Beaumont, Jennifer L, Watt, Rosemary, Barnathan, Elliot S, Victorson, David E

    “…Patient-reported outcome (PRO) measures have been developed to measure symptoms and other aspects of health-related quality of life. The Sarcoidosis Assessment…”
    Get full text
    Journal Article
  4. 4

    Associations between fluctuations in lung function and asthma control in two populations with differing asthma severity by Thamrin, Cindy, Nydegger, Regula, Stern, Georgette, Chanez, Pascal, Wenzel, Sally E, Watt, Rosemary A, FitzPatrick, Susan, Taylor, D Robin, Frey, Urs

    Published in Thorax (01-12-2011)
    “…Lung function is a major criterion used to assess asthma control. Fluctuation analyses can account for lung function history over time, and may provide an…”
    Get more information
    Journal Article
  5. 5

    Systemic inflammatory profile and response to anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease by Loza, Matthew J, Watt, Rosemary, Baribaud, Frédéric, Barnathan, Elliot S, Rennard, Stephen I

    Published in Respiratory research (02-02-2012)
    “…Chronic obstructive pulmonary disease (COPD) is characterized by progressive worsening of airflow limitation associated with abnormally inflamed airways in…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Participation of c-myc Protein in DNA Synthesis of Human Cells by Studzinski, George P., Brelvi, Zamir S., Feldman, Susan C., Watt, Rosemary A.

    “…The protein product of oncogene c-myc is believed to be important in regulation of the cell cycle. However, its direct role in DNA synthesis has not been…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Transcriptionally Active C-Myc Oncogene is Contained within NIARD, a DNA Sequence Associated with Chromosome Translocations in B-Cell Neoplasia by Marcu, Kenneth B., Harris, Linda J., Stanton, Lawrence W., Erikson, Jan, Watt, Rosemary, Croce, Carlo M.

    “…NIARD (non-immunoglobulin-associated rearranging DNA) is located on mouse chromosome 15 at the break point of a commonly observed translocation event involving…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1 by HEIKKILA, R, SCHWAB, G, WICKSTROM, E, SHEE LOONG LOKE, PLUZNIK, D. H, WATT, R, NECKERS, L. M

    Published in Nature (London) (30-07-1987)
    “…Initiation of T-lymphocyte proliferation by mitogen or antigen involves a cascade of gene activation events. Thus, by the time mitogen-activated T cells have…”
    Get full text
    Journal Article
  13. 13

    Polysome-dependent in vitro translation system capable of peptide chain reinitiation by Aroskar, Vivek A, Watt, Rosemary A, Emeh, John K, Niranjan, Banavadi G, Biunno, Ida, Avadhani, Narayan G

    Published in Biochemistry (Easton) (01-12-1980)
    “…A sensitive in vitro translation system has been developed which makes use of cellular polysomes as the source of mRNA and ribosomes. The soluble factors are…”
    Get full text
    Journal Article
  14. 14

    Microinjected c-myc as a Competence Factor by Kaczmarek, Leszek, Hyland, Julia K., Watt, Rosemary, Rosenberg, Martin, Baserga, Renato

    “…While a number of oncogenes are expressed in a cell cycle--dependent manner, their role in the control of cell proliferation can only be established by a…”
    Get full text
    Journal Article
  15. 15

    Translocation, breakage and truncated transcripts of c- myc oncogene in murine plasmacytomas by Stanton, Lawrence W, Watt, Rosemary, Marcu, Kenneth B

    Published in Nature (London) (02-06-1983)
    “…Comparative nucleotide sequence analysis of a rearranged c-myc gene in a murine plasmacytoma and c-myc cDNA from normal spleen reveals that chromosomal…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Differential Expression of the Translocated and the Untranslocated c-myc Oncogene in Burkitt Lymphoma by Ar-Rushdi, Abbas, Nishikura, Kazuko, Erikson, Jan, Watt, Rosemary, Rovera, Giovanni, Croce, Carlo M.

    “…Burkitt lymphoma cells carrying either a rearranged or unrearranged c-myc oncogene were examined with the use of probes from the 5′ exon and for the second and…”
    Get full text
    Journal Article
  18. 18

    Differential Expression of the Normal and of the Translocated Human c-myc Oncogenes in B Cells by Nishikura, Kazuko, Ab-Rushdi, Abbas, Erikson, Jan, Watt, Rosemary, Rovera, Giovanni, Croce, Carlo M.

    “…We have investigated whether the translocated and the untranslocated human c-myc oncogenes of Burkitt lymphoma cells are equally or differentially expressed in…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes by Blomhoff, H K, Smeland, E B, Beiske, K, Blomhoff, R, Ruud, E, Bjøro, T, Pfeifer-Ohlsson, S, Watt, R, Funderud, S, Godal, T

    Published in Journal of cellular physiology (01-06-1987)
    “…Cyclic AMP functions as a negative regulator of cell proliferation in a variety of cell systems. We show here that the proliferation of normal and neoplastic B…”
    Get more information
    Journal Article